30 October 2015
KNOW MORE CORBION'S BOARD OF MANAGEMENT
CEO CORBION
DETAILS
Key financial highlights Q3 2015:
Net sales organic growth in Q3 was 4.6%;
volume growth was 0.3%
EBITDA before one-off items in Q3
was € 39.8 million, an organic increase of 18.2%
EBITDA margin before one-off items was 16.9%
in Q3 (Q3 2014: 13.9%)
Our productivity improvement program Streamline
is on track, with a positive impact on Q3 2015
EBITDA of € 4.2 million
One-off benefit due to insurance proceeds
in connection with the Grandview incident earlier
in the year
We finalized our € 50 million share buyback program
Corbion reported Q3 2015 sales of € 235.6 million,
an increase of 18.6% compared to Q3 2014.
Organic sales growth was 4.6%,
mostly driven by price/mix improvements.
EBITDA excluding one-off items in Q3 2015
increased by 44.2% to € 39.8 million.
Outlook For 2015,
in our business unit Biobased Ingredients,
we expect full year growth to be near
the upper end of the guidance range of 2-4%.
In Biobased Innovations
we continue to expect higher R&D activity levels in Q4,
causing increased costs in the quarter.
As the fourth quarter is usually the slowest quarter
in the year we continue to expect
Corbion EBITDA before one-off items in H2
to come in slightly below
that of H1 2015 (€ 77.1 million).
For more information, please contact Corbion:
Press:
Saskia Nuijten,
Director Corporate Communications
T +31 (0)20 590 6320,
M +31 (0)6 21 812 453
Analysts and investors:
Jeroen van Harten,
Director Investor Relations
T +31 (0)20 5906293,
M +31(0)6 21 577 086
WWW.CHEMWINFO.COM BY KHUN PHICHAI
